Basel, September 29, 2025 - Novartis today announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer ...
At Novartis, we don’t just discover life-changing medicines, we're part of a broader effort to help ensure medicines reach the people who need them most, wherever they live, because the true value of ...
DARe is currently investigating three fundamental processes associated with aging and age-related diseases that have potential to deliver novel therapeutic approaches. These processes are intricately ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
85% of patients on Leqvio plus individually optimized lipid-lowering therapy (LLT) achieved LDL-C targets within 90 days vs. 31% of patients on placebo plus LLT 1 Patients on Leqvio plus LLT were 43% ...
Tato zpráva se zabývá naší činností, strategií a výkonností. Zdůrazňuje pokrok v plnění našich cílů v oblasti ESG a popisuje, jak vytváříme udržitelnou hodnotu pro různé zainteresované strany. Řídí se ...
Access & Reimbursement Manager (ARM) - Southern FLA (Remote) Regular, Full time Universal Hierarchy Node USA +Alternative Locations Field Non-Sales (USA) Set 24, 2025 ...
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback